You've reached the limit for free Overall Ranking scores. For more information, request a demo.
See CSRHub in Action
You have a total of 10 free searches available.
| Low 0-29 | 30-39 | 40-49 | 50-59 | 60-79 | 80-100 High |
Bentley Pharmaceuticals, Inc. was acquired by Teva Pharmaceutical Industries in July of 2008. Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, above 80% of Teva's sales, which totaled US$11.1 billion in 2008, are in North America and Europe. Teva has over 38,000 employees worldwide and production facilities in Israel, North America, Europe and Latin America.
Acquired by TEVA Pharmaceutical Industries in April of 2008
| Ticker: | BNT |
| ISIN: | US0826571079 |
| Address: |
2 Holland Way |
| Exeter, NH, 03833, USA | |
| Website: | Bentley Pharmaceuticals, Inc. |
| Phone #: | 603-658-6100 |
| ESG Web Area: | Subscribers Only ? |
| Industry: | Pharmaceutical & Medicine Manufacturing |
We considered many names for our site—in fact we spent our first year and a half under a different name—EkoHub. We liked “Eko” — coming from the Greek word Oikos, related to economy, ecology, and “home” or social concerns. From the beginning, we believed the word “Hub” reflected our desire to be at the center of the sustainability area, providing knowledge, harmony, and consensus among the hundreds of experts judging the ESG performance of companies.